{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:17:37Z","timestamp":1788585457666,"version":"build-2803163510"},"reference-count":44,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.5551\/jat.66218","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:10:00Z","timestamp":1781647800000},"page":"1194-1204","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPAR\u03b1 Modulator Pemafibrate"],"prefix":"10.5551","volume":"33","author":[{"given":"Tomoko","family":"Otsuki","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawachi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Komuku","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamanishi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hanada","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Immuno-Biological Laboratories Co., Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nordestgaard BG, Varbo A: Triglycerides and cardiovascular disease. Lancet, 2014; 384: 626-635","DOI":"10.1016\/S0140-6736(14)61177-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nordestgaard BG: Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res, 2016; 118: 547-563","DOI":"10.1161\/CIRCRESAHA.115.306249"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Goldberg RB, Chait A: A comprehensive update on the chylomicronemia syndrome. Front Endocrinol (Lausanne), 2020; 11: 593931","DOI":"10.3389\/fendo.2020.593931"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lookene A, Zhang L, Hultin M, Olivecrona G: Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J Biol Chem, 2004; 279: 49964-49972","DOI":"10.1074\/jbc.M407419200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Beigneux AP, Allan CM, Sandoval NP, Cho GW, Heizer PJ, Jung RS, Stanhope KL, Havel PJ, Birrane G, Meiyappan M, Gill 4th JE, Murakami M, Miyashita K, Nakajima K, Ploug M, Fong LG, Young SG: Lipoprotein lipase is active as a monomer. Proc Natl Acad Sci USA, 2019; 116: 6319-6328","DOI":"10.1073\/pnas.1900983116"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gunn KH, Roberts BS, Wang F, Strauss JD, Borgnia MJ, Egelman EH, Neher SB: The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage. Proc Natl Acad Sci USA, 2020; 117: 10254-10264","DOI":"10.1073\/pnas.1916555117"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Goldberg IJ: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab, 2001; 86: 965-971","DOI":"10.1210\/jcem.86.3.7304"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Taskinen MR, Nikkil\u00e4 EA: Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment. Diabetologia, 1979; 17: 351-356","DOI":"10.1007\/BF01236268"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Okazaki H, Gotoda T, Ogura M, Ishibashi S, Inagaki K, Daida H, Hayashi T, Hori M, Masuda D, Matsuki K, Yokoyama S, Harada-Shiba M: Current diagnosis and management of primary chylomicronemia. J Atheroscler Thromb, 2021; 28: 883-904","DOI":"10.5551\/jat.RV17054"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hegele RA, Berberich AJ, Ban MR, Wang J, Digenio A, Alexander VJ, D\u2019Erasmo L, Arca M, Jones A, Bruckert E, Stroes ES, Bergeron J, Civeira F, Witztum JL, Gaudet D: Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. J Clin Lipidol, 2018; 12: 920-927.e4","DOI":"10.1016\/j.jacl.2018.03.093"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yuasa-Kawase M, Masuda D, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Tsubakio-Yamamoto K, Ohama T, Matsuyama A, Nishida M, Ishigami M, Kawamoto T, Komuro I, Yamashita S: Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J Atheroscler Thromb, 2012; 19: 263-275","DOI":"10.5551\/jat.10603"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, Yoshida S: Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta, 1993; 216: 113-123","DOI":"10.1016\/0009-8981(93)90144-S"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, Tsuji M, Ide H, Miller IP, Miller NE, Hattori H: A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res, 2005; 46: 2015-2022","DOI":"10.1194\/jlr.D500018-JLR200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Miyashita K, Fukamachi I, Nagao M, Ishida T, Kobayashi J, Machida T, Nakajima K, Murakami M, Ploug M, Beigneux AP, Young SG, Nakajima K: An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum. J Clin Lipidol, 2018; 12: 203-210.e1","DOI":"10.1016\/j.jacl.2017.10.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tada H, Kawashiri M-A, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, Yamagishi M: Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol, 2018; 12: 1436-1444","DOI":"10.1016\/j.jacl.2018.08.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Beigneux AP, Davies BSJ, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding Z-M, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG: Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab, 2007; 5: 279-291","DOI":"10.1016\/j.cmet.2007.02.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Young SG, Davies BS, Voss CV, Gin P, Weinstein MM, Tontonoz P, Reue K, Bensadoun A, Fong LG, Beigneux AP: GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J Lipid Res, 2011; 52: 1869-1884","DOI":"10.1194\/jlr.R018689"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden MR, Gin P, Davies BS, Weinstein MM, Fong LG, Beigneux AP, Young SG, Olivecrona T, Hernell O: Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res, 2010; 51: 1535-1545","DOI":"10.1194\/jlr.M002717"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BS, Kuivenhoven JA, Kastelein JJ, Fong LG, Dallinga-Thie GM, Young SG: Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol, 2009; 29: 956-962","DOI":"10.1161\/ATVBAHA.109.186577"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wang J, Hegele RA: Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis, 2007; 6: 23","DOI":"10.1186\/1476-511X-6-23"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sustar U, Groselj U, Khan SA, Shafi S, Khan I, Kovac J, Bizjan BJ, Battelino T, Sadiq F: A homozygous variant in the GPIHBP1 gene in a child with severe hypertriglyceridemia and a systematic literature review. Front Genet, 2022; 13: 983283","DOI":"10.3389\/fgene.2022.983283"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Herrera E: Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 2002; 19: 43-55","DOI":"10.1385\/ENDO:19:1:43"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Basaran A: Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci, 2009; 16: 431-437","DOI":"10.1177\/1933719108330569"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Brahm AJ, Hegele RA: Chylomicronaemia\u2014current diagnosis and future therapies. Nat Rev Endocrinol, 2015; 11: 352-362","DOI":"10.1038\/nrendo.2015.26"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Valdivielso P, Ram\u00edrez-Bueno A, Ewald N: Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med, 2014; 25: 689-694","DOI":"10.1016\/j.ejim.2014.08.008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Scherer J, Singh VP, Pitchumoni CS, Yadav D: Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol, 2014; 48: 195-203","DOI":"10.1097\/01.mcg.0000436438.60145.5a"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wang GJ, Gao CF, Wei D, Wang C, Ding SQ: Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol, 2009; 15: 1427-1430","DOI":"10.3748\/wjg.15.1427"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Navina S, Acharya C, DeLany JP, Orlichenko LS, Baty CJ, Shiva SS, Durgampudi C, Karlsson JM, Lee K, Bae KT, Furlan A, Behari J, Liu S, McHale T, Nichols L, Papachristou GI, Yadav D, Singh VP: Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med, 2011; 3: 107-110","DOI":"10.1126\/scitranslmed.3002573"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AFH, Stroes E, Taskinen M-R, Tybj\u00e6rg-Hansen A, Watts GF, Wiklund O; European Atherosclerosis Society Consensus Panel: The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol, 2014; 2: 655-666","DOI":"10.1016\/S2213-8587(13)70191-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Moulin P, Dufour R, Averna M, Arca M, Cefal\u00f9 AB, Noto D, D\u2019Erasmo L, Di Costanzo A, Mar\u00e7ais C, Alvarez-Sala Walther LA, Banach M, Bor\u00e9n J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pint\u00f3 X, Reiner \u017d, Roeters van Lennep J, Soran H, Stefanutti C, Stroes E, Bruckert E: Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an \u201cFCS score\u201d. Atherosclerosis, 2018; 275: 265-272","DOI":"10.1016\/j.atherosclerosis.2018.06.814"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Moulin P, Dufour R, Averna M, Arca M, Cefal\u00f9 AB, Noto D, D\u2019Erasmo L, Di Costanzo A, Mar\u00e7ais C, Alvarez-Sala Walther LA, Banach M, Bor\u00e9n J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pint\u00f3 X, Reiner \u017d, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E: Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score. Data Brief, 2018; 21: 1334-1336","DOI":"10.1016\/j.dib.2018.10.125"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Stroes E, Moulin P, Parhofer KG, Rebours V, L\u00f6hr J-M, Averna M: Diagnostic algorithm for familial chylomicronemia syndrome. Atherosclerosis Suppl, 2017; 23: 1-7","DOI":"10.1016\/j.atherosclerosissup.2016.10.002"},{"key":"33","unstructured":"33) Burnett JR, Hooper AJ, Hegele RA: Familial lipoprotein lipase deficiency. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132026. 1999 Oct 12 [updated 2017 Jun 22]"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Hegele RA: Approach to the adult patient with chylomicronemia. J Clin Endocrinol Metab, 2026; 111: 845-859","DOI":"10.1210\/clinem\/dgaf701"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Toskes PP: Hyperlipidemic pancreatitis. Gastroenterol Clin North Am, 1990; 19: 783-791","DOI":"10.1016\/S0889-8553(21)00513-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Thajer A, Skacel G, de Gier C, Greber-Platzer S: The effect of a fat-restricted diet in four patients with familial chylomicronemia syndrome: a long-term follow-up study. Children (Basel), 2021; 8: 1078","DOI":"10.3390\/children8111078"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cooper AD: Hepatic uptake of chylomicron remnants. J Lipid Res, 1997; 38: 2173-2192","DOI":"10.1016\/S0022-2275(20)34932-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Khetarpal SA, Vitali C, Levin MG, Klarin D, Park J, Pampana A, Millar JS, Kuwano T, Sugasini D, Subbaiah PV, Billheimer JT, Natarajan P, Rader DJ: Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins. PLoS Genet, 2021; 17: e1009802","DOI":"10.1371\/journal.pgen.1009802"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Cushing EM, Sylvers KL, Chi X, Shetty SK, Davies BSJ: Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-\/-Gpihbp1-\/- mice. J Lipid Res, 2018; 59: 1230-1243","DOI":"10.1194\/jlr.M084749"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group: Efficacy and safety of pemafibrate versus fenofibrate in patients with high triglyceride and low HDL cholesterol levels: a multicenter, placebo-controlled, double-blind, randomized trial. J Atheroscler Thromb, 2018; 25: 521-538","DOI":"10.5551\/jat.44412"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Iitake C, Masuda D, Koseki M, Yamashita S: Marked effects of novel selective peroxisome proliferator-activated receptor \u03b1 modulator, pemafibrate in severe hypertriglyceridemia: preliminary report. Cardiovasc Diabetol, 2020; 19: 201","DOI":"10.1186\/s12933-020-01172-8"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ueda H, Mineo R, Sugiyama T, Koseki M, Itoh Y, Iwamoto R, Tamba S, Yamamoto K, Yamada Y, Hiraoka H, Matsuzawa Y: A man with primary hyperchylomicronemia with triglyceride levels exceeding 11,000 mg\/dL was well controlled by pemafibrate combined with dietary therapy. Intern Med, 2024; 64: 741-747","DOI":"10.2169\/internalmedicine.3946-24"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Miyauchi S, Utsunomiya Y, Okamoto M, Akesaka K, Ono K, Hara Y, Miyazaki M, Nakaguchi H, Miyake T, Furukawa S, Ebisui O, Hiasa Y, Matsuura B: Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate. Endocrinol Diabetes Metab Case Rep, 2026; 2026: EDM250084","DOI":"10.1530\/EDM-25-0084"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Tomlinson B, Wu QY, Zhong YM, Li YH: Advances in dyslipidaemia treatments: focusing on apoC3 and ANGPTL3 inhibitors. J Lipid Atheroscler, 2024; 13: 2-20","DOI":"10.12997\/jla.2024.13.1.2"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/9\/33_66218\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:52:36Z","timestamp":1788583956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/9\/33_66218\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.66218","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"66218"}}